HuGE Literature Finder
Records 1-8
TERT mutations correlate with higher TMB value and unique tumor microenvironment and may be a potential biomarker for anti-CTLA4 treatment.
Cancer medicine 2020 Aug . Li Huahua, Li Jia, Zhang Chenyue, Zhang Chenxing, Wang Haiyo |
Combined analysis of keratinocyte cancers identifies novel genome-wide loci.
![]() Human molecular genetics 2019 09 28 (18): 3148-3160. Liyanage Upekha E, Law Matthew H, Han Xikun, An Jiyuan, Ong Jue-Sheng, Gharahkhani Puya, Gordon Scott, Neale Rachel E, Olsen Catherine M, , MacGregor Stuart, Whiteman David |
Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy.
Nature genetics 2016 Sep . Riaz Nadeem, Havel Jonathan J, Kendall Sviatoslav M, Makarov Vladimir, Walsh Logan A, Desrichard Alexis, Weinhold Nils, Chan Timothy |
Genomic correlates of response to CTLA4 blockade in metastatic melanoma.
Science (New York, N.Y.) 2015 Sep . Van Allen Eliezer M, Miao Diana, Schilling Bastian, Shukla Sachet A, Blank Christian, Zimmer Lisa, Sucker Antje, Hillen Uwe, Geukes Foppen Marnix H, Goldinger Simone M, Utikal Jochen, Hassel Jessica C, Weide Benjamin, Kaehler Katharina C, Loquai Carmen, Mohr Peter, Gutzmer Ralf, Dummer Reinhard, Gabriel Stacey, Wu Catherine J, Schadendorf Dirk, Garraway Levi |
Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-? but Not Observation in Intermediate Risk Melanoma Patients.
PloS one 2015 10 (7): e0132745. Tarhini Ahmad A, Lin Yan, Zahoor Haris, Shuai Yongli, Butterfield Lisa H, Ringquist Steven, Gogas Helen, Sander Cindy, Lee Sandra, Agarwala Sanjiv S, Kirwood John |
Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?
Cancer immunology, immunotherapy : CII 2010 Feb 59 (2): 303-12. Bouwhuis Marna G, Gast Andreas, Figl Adina, Eggermont Alexander M M, Hemminki Kari, Schadendorf Dirk, Kumar Raj |
CTLA4 variants, UV-induced tolerance, and risk of non-melanoma skin cancer.
Cancer research 2009 Aug 69 (15): 6158-63. Welsh Marleen M, Applebaum Katie M, Spencer Steven K, Perry Ann E, Karagas Margaret R, Nelson Heather |
Influence of cytotoxic T lymphocyte-associated antigen 4 (CTLA4) common polymorphisms on outcome in treatment of melanoma patients with CTLA-4 blockade.
Journal of immunotherapy (Hagerstown, Md. : 1997) 0 31 (6): 586-90. Breunis Willemijn B, Tarazona-Santos Eduardo, Chen Renee, Kiley Maureen, Rosenberg Steven A, Chanock Stephen |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 19, 2021
- Content source: